Published January 1, 2022
| Version v1
Journal article
Open
The Anti-HIV Drug Nelfinavir Exhibits Synergistic Activity with Tyrosine Kinase Inhibitors and Circumvents TKI-Resistance Conferred By T315I-Mutated BCR-ABL
- 1. Inserm U1310, Villejuif, France
- 2. Univ Paris Saclay, Inserm U1310, Villejuif, France
- 3. CITH Era Ctr iPSC Therapies, Inserm UMS 45, Evry, France
Description
Öz bulunamadı.
Files
bib-ec499fb2-854d-4f2b-9b30-757ba8fe9599.txt
Files
(249 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:2f45c4da000c5bda4e64ba838042dc0f
|
249 Bytes | Preview Download |